Encore Wire Corp. (WIRE) Jumps 5.21% on February 19

Equities Staff |

Encore Wire Corp. (WIRE) was among the biggest gainers on the Russell 2000 for Friday February 19 as the stock popped 5.21% to $35.14, representing a gain of $1.74 per share. Some 211,851 shares traded hands on 1,923 trades, compared with an average daily volume of 101,706 shares out of a total float of 20.67 million. The stock opened at $33.66 and traded with an intraday range of $35.88 to $33.00.

After today's gains, Encore Wire Corp. reached a market cap of $726.26 million. Encore Wire Corp. has had a trading range between $48.50 and $30.23 over the last year, and it had a 50-day SMA of $36.55 and a 200-day SMA of $38.83.

The stock has a P/E Ratio of 16.7.

Encore Wire Corp is engaged in manufacturing electric building wire & cable. It supplies building wire for interior electrical wiring in commercial and industrial buildings, homes, apartments, and manufactured housing.

Encore Wire Corp. is based out of McKinney, TX and has some 1,182 employees. Its CEO is Daniel L. Jones.

For a complete fundamental analysis analysis of Encore Wire Corp., check out Equities.com’s Stock Valuation Analysis report for WIRE. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…


Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…